Literature DB >> 17200418

Conjugated bile acids regulate hepatocyte glycogen synthase activity in vitro and in vivo via Galphai signaling.

Youwen Fang1, Elaine Studer, Clint Mitchell, Steven Grant, William M Pandak, Philip B Hylemon, Paul Dent.   

Abstract

The regulation of glycogen synthase activity by bile acids in primary hepatocytes and in the intact liver was investigated. Bile acids (deoxycholic acid, DCA; taurocholic acid, TCA) activated AKT and glycogen synthase (GS) in primary rat hepatocytes. Incubation with a phosphatidyl inositol-3 kinase inhibitor or expression of dominant-negative AKT in primary rat hepatocytes abolished activation of AKT and GS by DCA and TCA. TCA, but not DCA, activated Galpha(i) proteins in primary rat hepatocytes. Treatment of cells with pertussis toxin or expression of dominant-negative Galpha(i) blocked TCA-induced activation of AKT and of GS but did not alter AKT or GS activation caused by DCA. TCA caused activation of AKT and GS in intact rat liver. Expression of dominant-negative Galpha(i) reduced TCA-induced activation of AKT and of GS in intact rat liver. Together, our findings demonstrate that bile acids are physiological regulators of glycogen synthase in rat liver and that conjugated bile acids use a Galpha(i)-coupled G protein-coupled receptor to regulate GS activity in vitro and in vivo.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17200418     DOI: 10.1124/mol.106.032060

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  23 in total

1.  Conjugated bile acids activate the sphingosine-1-phosphate receptor 2 in primary rodent hepatocytes.

Authors:  Elaine Studer; Xiqiao Zhou; Renping Zhao; Yun Wang; Kazuaki Takabe; Masayuki Nagahashi; William M Pandak; Paul Dent; Sarah Spiegel; Ruihua Shi; Weiren Xu; Xuyuan Liu; Pat Bohdan; Luyong Zhang; Huiping Zhou; Phillip B Hylemon
Journal:  Hepatology       Date:  2011-11-30       Impact factor: 17.425

2.  Phosphatidylinositol-3-kinase p110γ contributes to bile salt-induced apoptosis in primary rat hepatocytes and human hepatoma cells.

Authors:  Simon Hohenester; Anna Gates; Ralf Wimmer; Ulrich Beuers; M Sawkat Anwer; Christian Rust; Cynthia R L Webster
Journal:  J Hepatol       Date:  2010-07-17       Impact factor: 25.083

3.  Sphingosine Kinases/Sphingosine 1-Phosphate Signaling in Hepatic Lipid Metabolism.

Authors:  Eric K Kwong; Xiaojiaoyang Li; Phillip B Hylemon; Huiping Zhou
Journal:  Curr Pharmacol Rep       Date:  2017-06-20

4.  Bile acids as global regulators of hepatic nutrient metabolism.

Authors:  Phillip B Hylemon; Kazuaki Takabe; Mikhail Dozmorov; Masayuki Nagahashi; Huiping Zhou
Journal:  Liver Res       Date:  2017-04-26

5.  Bile acid stimulates hepatocyte polarization through a cAMP-Epac-MEK-LKB1-AMPK pathway.

Authors:  Dong Fu; Yoshiyuki Wakabayashi; Jennifer Lippincott-Schwartz; Irwin M Arias
Journal:  Proc Natl Acad Sci U S A       Date:  2011-01-10       Impact factor: 11.205

6.  Reply.

Authors:  Phillip Hylemon; Masayuki Nagahashi; Kazuaki Takabe; Huiping Zhou
Journal:  Hepatology       Date:  2015-07-31       Impact factor: 17.425

Review 7.  Bile acids are nutrient signaling hormones.

Authors:  Huiping Zhou; Phillip B Hylemon
Journal:  Steroids       Date:  2014-05-10       Impact factor: 2.668

8.  Tauroursodeoxycholic Acid may improve liver and muscle but not adipose tissue insulin sensitivity in obese men and women.

Authors:  Marleen Kars; Ling Yang; Margaret F Gregor; B Selma Mohammed; Terri A Pietka; Brian N Finck; Bruce W Patterson; Jay D Horton; Bettina Mittendorfer; Gökhan S Hotamisligil; Samuel Klein
Journal:  Diabetes       Date:  2010-06-03       Impact factor: 9.461

Review 9.  The roles of bile acids and sphingosine-1-phosphate signaling in the hepatobiliary diseases.

Authors:  Masayuki Nagahashi; Kizuki Yuza; Yuki Hirose; Masato Nakajima; Rajesh Ramanathan; Nitai C Hait; Phillip B Hylemon; Huiping Zhou; Kazuaki Takabe; Toshifumi Wakai
Journal:  J Lipid Res       Date:  2016-07-26       Impact factor: 5.922

10.  Role of nuclear receptors in lipid dysfunction and obesity-related diseases.

Authors:  Hollie I Swanson; Taira Wada; Wen Xie; Barbara Renga; Angela Zampella; Eleonora Distrutti; Stefano Fiorucci; Bo Kong; Ann M Thomas; Grace L Guo; Ramesh Narayanan; Muralimohan Yepuru; James T Dalton; John Y L Chiang
Journal:  Drug Metab Dispos       Date:  2012-10-04       Impact factor: 3.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.